Windlas Biotech Limited (WINDLAS) — Capital Reinvestment Ratio
Windlas Biotech Limited (WINDLAS) has a Capital Reinvestment Ratio of 0.77x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs681.87 Million) in capital expenditures (Rs521.94 Million). Check Windlas Biotech Limited (WINDLAS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Windlas Biotech Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Windlas Biotech Limited's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Windlas Biotech Limited.
Annual Capital Reinvestment Ratio for Windlas Biotech Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Windlas Biotech Limited from 2018 to 2025. See WINDLAS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | Rs681.87 Million | Rs521.94 Million | ▲ +121.3% |
| 2024 | 0.35x | Rs1.09 Billion | Rs376.84 Million | ▼ -70.3% |
| 2023 | 1.16x | Rs609.65 Million | Rs708.90 Million | ▼ -28.3% |
| 2022 | 1.62x | Rs91.30 Million | Rs148.04 Million | ▲ +217.6% |
| 2021 | 0.51x | Rs114.54 Million | Rs58.47 Million | ▼ -16.6% |
| 2020 | 0.61x | Rs250.06 Million | Rs153.10 Million | ▲ +27.6% |
| 2019 | 0.48x | Rs186.54 Million | Rs89.54 Million | ▼ -44.9% |
| 2018 | 0.87x | Rs295.91 Million | Rs257.82 Million | — |